Depreciation of Evolent Health, Inc. from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Evolent Health, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • Evolent Health, Inc. Depreciation for the quarter ending 31 Dec 2025 was $6,300,000, a 15% decline year-over-year.
  • Evolent Health, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $26,300,000, a 13% decline year-over-year.
  • Evolent Health, Inc. annual Depreciation for 2025 was $26,300,000, a 13% decline from 2024.
  • Evolent Health, Inc. annual Depreciation for 2024 was $30,300,000, a 6.5% decline from 2023.
  • Evolent Health, Inc. annual Depreciation for 2023 was $32,400,000, a 1.2% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Evolent Health, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $26,300,000 $6,300,000 -$1,100,000 -15% 01 Oct 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 $27,400,000 $6,300,000 -$1,200,000 -16% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $28,600,000 $6,400,000 -$1,500,000 -19% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $30,100,000 $7,300,000 -$200,000 -2.7% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $30,300,000 $7,400,000 -$200,000 -2.6% 01 Oct 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 $30,500,000 $7,500,000 -$1,000,000 -12% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $31,500,000 $7,900,000 -$300,000 -3.7% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $31,800,000 $7,500,000 -$600,000 -7.4% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025 2025 Q1
Q4 2023 $32,400,000 $7,600,000 -$1,300,000 -15% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $33,700,000 $8,500,000 +$800,000 +10% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $32,900,000 $8,200,000 +$400,000 +5.1% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $32,500,000 $8,100,000 +$500,000 +6.6% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $32,000,000 $8,900,000 +$1,100,000 +14% 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
Q3 2022 $30,900,000 $7,700,000 +$300,000 +4.1% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $30,600,000 $7,800,000 +$200,000 +2.6% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $30,400,000 $7,600,000 -$200,000 -2.6% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $30,600,000 $7,800,000 +$700,000 +9.9% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
Q3 2021 $29,900,000 $7,400,000 +$100,000 +1.4% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $29,800,000 $7,600,000 +$500,000 +7% 01 Apr 2021 30 Jun 2021 10-Q 03 Aug 2022 2022 Q2
Q1 2021 $29,300,000 $7,800,000 +$1,000,000 +15% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $28,300,000 $7,100,000 +$700,000 +11% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
Q3 2020 $27,600,000 $7,300,000 +$1,300,000 +22% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $26,300,000 $7,100,000 +$1,400,000 +25% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $24,900,000 $6,800,000 +$1,600,000 +31% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 FY
Q4 2019 $23,300,000 $6,400,000 +$900,000 +16% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $22,400,000 $6,000,000 +$1,700,000 +40% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $20,700,000 $5,700,000 +$1,800,000 +46% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $18,900,000 $5,200,000 +$1,600,000 +44% 01 Jan 2019 31 Mar 2019 10-Q 28 May 2020 2020 Q1
Q4 2018 $17,300,000 $5,500,000 +$2,300,000 +72% 01 Oct 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
Q3 2018 $15,000,000 $4,300,000 +$2,000,000 +87% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $13,000,000 $3,900,000 +$2,000,000 +105% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $11,000,000 $3,600,000 +$1,800,000 +100% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $9,200,000 $3,200,000 +$3,000,000 +1500% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $6,200,000 $2,300,000 +$1,400,000 +156% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $4,800,000 $1,900,000 +$1,100,000 +138% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $3,700,000 $1,800,000 +$1,100,000 +157% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q4 2016 $2,600,000 $200,000 -$300,000 -60% 01 Oct 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
Q3 2016 $2,900,000 $900,000 +$400,000 +80% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $2,500,000 $800,000 +$600,000 +300% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017 2017 Q2
Q1 2016 $1,900,000 $700,000 +$700,000 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $1,200,000 $500,000 01 Oct 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
Q3 2015 $500,000 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $200,000 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q1 2015 $0 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1

Evolent Health, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $26,300,000 -$4,000,000 -13% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $30,300,000 -$2,100,000 -6.5% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $32,400,000 +$400,000 +1.2% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $32,000,000 +$1,400,000 +4.6% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $30,600,000 +$2,300,000 +8.1% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $28,300,000 +$5,000,000 +21% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2023 2022 FY
2019 $23,300,000 +$6,000,000 +35% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $17,300,000 +$8,100,000 +88% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021 2020 FY
2017 $9,200,000 +$6,600,000 +254% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $2,600,000 +$1,400,000 +117% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $1,200,000 +$1,200,000 01 Jan 2015 31 Dec 2015 10-K 01 Mar 2018 2017 FY
2014 $0 -$800,000 -100% 01 Jan 2014 31 Dec 2014 10-K 03 Mar 2017 2016 FY
2013 $800,000 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.